AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2018

May 8, 2018

284_dirs_2018-05-08_4e0cf74b-0cdd-4371-9ee4-3a274c0678c1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2018-05-04

Reporting Person: Zachary Jennifer (EVP, General Counsel)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-04	Restricted Stock Unit	$	A	17316.0000	Acquired	2021-05-04	Common Stock (17316.0000)	Direct
2018-05-04	Stock Option (right to buy)	$57.7500	A	73191.0000	Acquired	2028-05-03	Common Stock (73191.0000)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F2: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.

F3: The option vests and becomes exercisable in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.